chr6-160093509-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000876.4(IGF2R):​c.6656-2930T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.435 in 575,932 control chromosomes in the GnomAD database, including 57,111 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16323 hom., cov: 32)
Exomes 𝑓: 0.43 ( 40788 hom. )

Consequence

IGF2R
NM_000876.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.943

Publications

10 publications found
Variant links:
Genes affected
IGF2R (HGNC:5467): (insulin like growth factor 2 receptor) This gene encodes a receptor for both insulin-like growth factor 2 and mannose 6-phosphate. The binding sites for each ligand are located on different segments of the protein. This receptor has various functions, including in the intracellular trafficking of lysosomal enzymes, the activation of transforming growth factor beta, and the degradation of insulin-like growth factor 2. Mutation or loss of heterozygosity of this gene has been association with risk of hepatocellular carcinoma. The orthologous mouse gene is imprinted and shows exclusive expression from the maternal allele; however, imprinting of the human gene may be polymorphic, as only a minority of individuals showed biased expression from the maternal allele (PMID:8267611). [provided by RefSeq, Nov 2015]
CHP1P2 (HGNC:54896): (CHP1 pseudogene 2) This locus on chromosome 6q25.3 represents a single-exon transcribed pseudogene of the multi-exon calcium binding protein P22 gene which resides on chromosome 15q13.3. This pseudogene is situated within an intron region of the insulin-like growth factor 2 receptor gene (IGF2R). [provided by RefSeq, Jan 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.655 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGF2RNM_000876.4 linkc.6656-2930T>C intron_variant Intron 44 of 47 ENST00000356956.6 NP_000867.3 P11717
CHP1P2NR_003288.2 linkn.428T>C non_coding_transcript_exon_variant Exon 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGF2RENST00000356956.6 linkc.6656-2930T>C intron_variant Intron 44 of 47 1 NM_000876.4 ENSP00000349437.1 P11717

Frequencies

GnomAD3 genomes
AF:
0.453
AC:
68727
AN:
151840
Hom.:
16281
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.576
Gnomad AMI
AF:
0.395
Gnomad AMR
AF:
0.446
Gnomad ASJ
AF:
0.379
Gnomad EAS
AF:
0.674
Gnomad SAS
AF:
0.468
Gnomad FIN
AF:
0.359
Gnomad MID
AF:
0.519
Gnomad NFE
AF:
0.380
Gnomad OTH
AF:
0.447
GnomAD4 exome
AF:
0.429
AC:
181807
AN:
423974
Hom.:
40788
Cov.:
0
AF XY:
0.429
AC XY:
99287
AN XY:
231204
show subpopulations
African (AFR)
AF:
0.587
AC:
6898
AN:
11746
American (AMR)
AF:
0.495
AC:
12242
AN:
24708
Ashkenazi Jewish (ASJ)
AF:
0.369
AC:
4114
AN:
11148
East Asian (EAS)
AF:
0.687
AC:
17694
AN:
25766
South Asian (SAS)
AF:
0.478
AC:
25011
AN:
52304
European-Finnish (FIN)
AF:
0.367
AC:
12109
AN:
32962
Middle Eastern (MID)
AF:
0.487
AC:
1230
AN:
2526
European-Non Finnish (NFE)
AF:
0.387
AC:
93124
AN:
240692
Other (OTH)
AF:
0.424
AC:
9385
AN:
22122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
4897
9794
14690
19587
24484
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.453
AC:
68816
AN:
151958
Hom.:
16323
Cov.:
32
AF XY:
0.452
AC XY:
33611
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.577
AC:
23890
AN:
41414
American (AMR)
AF:
0.446
AC:
6813
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.379
AC:
1315
AN:
3466
East Asian (EAS)
AF:
0.674
AC:
3473
AN:
5154
South Asian (SAS)
AF:
0.468
AC:
2249
AN:
4810
European-Finnish (FIN)
AF:
0.359
AC:
3801
AN:
10578
Middle Eastern (MID)
AF:
0.517
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
0.380
AC:
25807
AN:
67948
Other (OTH)
AF:
0.453
AC:
957
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1873
3746
5619
7492
9365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.417
Hom.:
37271
Bravo
AF:
0.468
Asia WGS
AF:
0.600
AC:
2086
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
2.8
DANN
Benign
0.62
PhyloP100
-0.94
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1888727; hg19: chr6-160514541; COSMIC: COSV63482176; COSMIC: COSV63482176; API